Clincosm LogoSign in Get a demo

clinically isolated syndrome

Showing 1 - 25 of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Visual Processing Speed and Objective Analysis of Ocular

Enrolling by invitation
  • Multiple Sclerosis
  • +3 more
  • Eye tracking
  • +3 more
  • Valladolid, Spain
    IOBA - Universidad de Valladolid
Jan 20, 2023

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome Trial in Hamburg (Understanding MRI in

Active, not recruiting
  • Multiple Sclerosis
  • +2 more
  • Understanding MRI in MS (website)
  • Control website
  • Hamburg, Germany
    University Medical Centre Hamburg-Eppendorf
Dec 5, 2022

MSPT Device in Routine Clinical Practice in Swiss Healthcare

Recruiting
  • Multiple Sclerosis
  • Clinically Isolated Syndrome
  • MSPT
  • Bern, Switzerland
    Inselspital Bern, Ambulantes Neurozentrum
Nov 1, 2022

Implementation ofNovel Functional Eye-Tracking Biomarker for

Recruiting
  • Clinically Isolated Syndrome
  • Relapsing Remitting Multiple Sclerosis
  • Eye-tracking
  • Montréal, Quebec, Canada
    Montreal Neurological Institute and Hospital
Sep 2, 2022

Multiple Sclerosis, Clinically Isolated Syndrome Trial in Worldwide (Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • Clinically Isolated Syndrome
  • San Francisco, California
  • +5 more
Aug 2, 2022

Multiple Sclerosis, Clinically Isolated Syndrome Trial in Worldwide (Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • Clinically Isolated Syndrome
  • San Francisco, California
  • +9 more
Aug 2, 2022

Multiple Sclerosis, Clinically Isolated Syndrome Trial in Iowa City (Immediate Autoimmune Intervention Mastery Course (AIM),

Active, not recruiting
  • Multiple Sclerosis
  • Clinically Isolated Syndrome
  • Immediate Autoimmune Intervention Mastery Course (AIM)
  • +3 more
  • Iowa City, Iowa
    Univeristy of Iowa
Jul 3, 2022

Relapsing Multiple Sclerosis, Clinically Isolated Syndrome Trial in San Francisco (Ocrelizumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Clinically Isolated Syndrome
  • San Francisco, California
    University of California San Francisco
Apr 28, 2022

Ocrelizumab in Breastmilk

Active, not recruiting
  • Multiple Sclerosis
  • Clinically Isolated Syndrome
  • San Francisco, California
    University of California, San Francisco
Mar 21, 2022

Multiple Sclerosis, Clinically Isolated Syndrome Trial in Bordeaux (blood sample, cerebro-spinal fluid)

Recruiting
  • Multiple Sclerosis
  • Clinically Isolated Syndrome
  • blood sample
  • cerebro-spinal fluid
  • Bordeaux, France
    CHU de Bordeaux - service de neurologie
Feb 2, 2022

MS-ResearchBiomarkerS

Recruiting
  • Multiple Sclerosis
  • +10 more
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jan 26, 2022

    Clinically Isolated Syndrome, Radiologically Isolated Syndrome, Multiple Sclerosis in Children Trial in Lomme (Tear collection

    Recruiting
    • Clinically Isolated Syndrome
    • +2 more
    • Tear collection and lumbar punction
    • Lomme, France
      GHICL
    Jan 5, 2022

    Clinically Isolated Syndrome, Relapsing Remitting Multiple Sclerosis Trial in Iowa City (Therapeutic diet and lifestyle)

    Active, not recruiting
    • Clinically Isolated Syndrome
    • Relapsing Remitting Multiple Sclerosis
    • Therapeutic diet and lifestyle
    • Iowa City, Iowa
      University of Iowa
    Dec 14, 2021

    Automatic Segmentation Software to Track Lesions in Multiple

    Active, not recruiting
    • Multiple Sclerosis
    • Clinically Isolated Syndrome
    • Analysis of cerebral MRI with automatic segmentation software
    • Nîmes, France
      CHU Nimes
    Dec 15, 2021

    CNS Inflammatory Demyelinating Diseases

    Not yet recruiting
    • Multiple Sclerosis
    • +4 more
    • Intravenous steroid
    • (no location specified)
    Nov 29, 2021

    Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome Trial in Beirut (Vitamin D3)

    Recruiting
    • Multiple Sclerosis
    • +4 more
    • Vitamin D3
    • Beirut, Lebanon
      Nehme & Therese Tohme Multiple Sclerosis Center
    Aug 27, 2021

    Risk Factors in Early Multiple Sclerosis

    Recruiting
    • Multiple Sclerosis
    • +4 more
    • Brain MRI
    • Aurora, Colorado
      University of Colorado Anschutz Medical Campus
    Aug 4, 2021

    Multiple Sclerosis (MS), Multiple Sclerosis (MS) Relapsing Remitting, Multiple Sclerosis (MS) Primary Progressive Trial in

    Completed
    • Multiple Sclerosis (MS)
    • +6 more
    • Video-oculography / Social cognition tasks / Neuropsychological evaluations
    • Monaco, Monaco
      Centre Mémoire / Centre de Gérontologie Clinique Rainier III / P
    Jan 19, 2021

    Multiple Sclerosis, Clinically Isolated Syndrome Trial in Calgary (Minocycline 100mg)

    Recruiting
    • Multiple Sclerosis
    • Clinically Isolated Syndrome
    • Minocycline 100mg
    • Calgary, Alberta, Canada
      Calgary MS Clinic at Foothills Medical Centre
    Feb 27, 2020

    Multiple Sclerosis, Clinically Isolated Syndrome Trial in Ulm (Immunoadsorption, Plasmapheresis)

    Completed
    • Multiple Sclerosis
    • Clinically Isolated Syndrome
    • Immunoadsorption
    • Plasmapheresis
    • Ulm, Baden-Württemberg, Germany
      Department of Neurology, University of Ulm
    Sep 10, 2019

    Mitochondrial Dysfunction and Disease Progression

    Completed
    • Clinically Isolated Syndrome
    • +3 more
      • New York, New York
        Icahn School of Medicine
      Feb 19, 2019

      Clinical Importance of Glucose Regulation in Relapsing MS

      Unknown status
      • Relapsing Remitting Multiple Sclerosis
      • Clinically Isolated Syndrome
        • Charlottesville, Virginia
          University of Virginia
        Nov 5, 2018

        Optic Neuritis, Multiple Sclerosis, Clinically Isolated Syndrome Trial in Copenhagen, Glostrup (Gluten-free diet)

        Unknown status
        • Optic Neuritis
        • +2 more
        • Gluten-free diet
        • Copenhagen, Frederiksberg, Denmark
        • +1 more
        May 1, 2018

        Relapsing Multiple Sclerosis, Clinically Isolated Syndrome Trial in Darmstadt (Rebif)

        Completed
        Has Results
        • Relapsing Multiple Sclerosis
        • Clinically Isolated Syndrome
        • Darmstadt, Germany
          Please contact the Merck KGaA Communication Center
        Mar 29, 2018

        Clinically Isolated Syndrome, Multiple Sclerosis Trial in Dublin (5000IU vitamin D, 10000IU vitamin D, Placebo)

        Completed
        • Clinically Isolated Syndrome
        • Multiple Sclerosis
        • 5000IU vitamin D
        • +2 more
        • Dublin, Dublin 4, Ireland
          St Vincent's University Hospital
        May 1, 2017